Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label attachment file name title
tabling member	label

Search

93821

registered interest
date	16/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Blood: Contamination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what mechanisms are in place for claimants of support from the (a) Macfarlane and Eileen Trust, (b) Skipton Fund, (c) Macfarlane Trust, (d) Eileen Trust and (e) Caxton Foundation to make complaints about and seek redress for level of support they receive; and what process those bodies use to decide entitlement to discretionary and non-discretionary support.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	210954
answer	answer is ministerial correction date of answer 21/10/2014 answer text <p>MFET Ltd and the Skipton Fund make fixed rate payments which are set by Government. If claimants are unhappy with the level of those payments they can write to the Department of Health. The payments policies of the Macfarlane Trust, Eileen Trust and Caxton Foundation are determined by their respective Trustees. People who are unhappy with the level of the payments they receive from any of these bodies can take it up with the relevant body.</p><p> </p><p> </p><p> </p><p>To establish eligibility in respect of HIV infection, claimants are required to provide as much relevant information as they have available, which is then considered by the Department. To establish eligibility in respect of hepatitis C infection, a claimant’s hepatologist provides the necessary information for the Skipton Fund. All claims are assessed on the balance of probabilities. People whose claims are rejected by the Skipton Fund can submit an appeal to the independent Appeals Panel. Entry into the system of financial support is through MFET Ltd in respect of HIV infection and the Skipton Fund in respect of hepatitis C infection.</p><p> </p><p> </p><p> </p><p>Once a claimant has been approved for payments from MFET Ltd and the Skipton Fund, they are also eligible to apply for discretionary support from the relevant discretionary body (the Macfarlane Trust for haemophiliacs with HIV or HIV and hepatitis C; the Eileen Trust for non-haemophiliacs with HIV or HIV and hepatitis C; the Caxton Foundation for people mono-infected with hepatitis C).</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 21/10/2014 16:08:33 answering member 3918 label Biography information for Jane Ellison
tabling member	1533 label Biography information for Dame Diana Johnson

93822

registered interest
date	16/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Blood: Contamination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much his Department has allocated in grants to the (a) Macfarlane and Eileen Trust, (b) Skipton Fund, (c) Macfarlane Trust, (d) Eileen Trust and (e) Caxton Foundation in each year since their inception; whether such funding is allocated at the discretion of his Department; whether the size of those grants in each year is determined on the basis of a formula; what representations his Department has received from each of those organisations in the last four years to the amounts allocated; what entities fund each such body; and what his Department's planned future funding allocations to those bodies are for the next five years.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	210955
answer	answer is ministerial correction date of answer 21/10/2014 answer text <p><strong> </strong></p><p> </p><p>The funding for the system of financial support for people infected with HIV and hepatitis C as a result of treatment with NHS supplied blood or blood products, is at the discretion of the four UK Health Departments. The Department of Health is the sole funder of MFET Ltd, the Macfarlane Trust and the Eileen Trust. All four UK Health Departments provide funding for the Skipton Fund and Caxton Foundation.</p><p> </p><p> </p><p> </p><p>A document outlining the grants that have been made to each of the schemes from 1988 to April 2014 is attached. Payments from the Skipton Fund and MFET Ltd are set by the UK Health Departments, and the Department provides sufficient funds to pay all approved claims. The budget allocations for the Macfarlane Trust, the Eileen Trust and the Caxton Foundation are discretionary and take account of what each received in the previous year and the Department’s other funding priorities. In the last four years, the Department has received one business case from Caxton Foundation and one from the Macfarlane Trust for an increase in their allocations. Funding allocations for Macfarlane Trust, the Eileen Trust and the Caxton Foundation for the next five years have not yet been decided.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 21/10/2014 16:16:20 answering member 3918 label Biography information for Jane Ellison attachment 1 file name Contaminated blood payments.xlsx title Grants made to each scheme from 1988- April 2014
tabling member	1533 label Biography information for Dame Diana Johnson

93832

registered interest
date	16/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Skipton Fund
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many appeals have been made to the Skipton Fund Appeals Panel in respect of decisions made by that fund; and how many such appeals were decided in favour of (a) the appellant or (b) the Skipton Fund.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	210937
answer	answer is ministerial correction date of answer 21/10/2014 answer text <p>The Skipton Fund Appeals Panel has considered 412 appeals in respect of decisions made by the Skipton Fund, since the Skipton Fund was established in 2004. 210 appeals were decided in favour of the appellant and 202 were decided in favour of the Skipton Fund.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 21/10/2014 15:53:50 answering member 3918 label Biography information for Jane Ellison
tabling member	1533 label Biography information for Dame Diana Johnson

93833

registered interest
date	16/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Blood: Contamination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many people who contracted HIV following treatment with NHS-supplied blood products from the 1970s to the early 1990s have also contracted (a) Stage 1 Hepatitis C and (b) Stage 2 Hepatitis C.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	210938
answer	answer is ministerial correction date of answer 21/10/2014 answer text <p>Based on data supplied by the Skipton Fund, 707 people who contracted HIV following treatment with NHS-supplied blood or blood products from the 1970s to the early 1990s have also received a stage 1 payment in respect of chronic hepatitis C infection contracted through their NHS treatment. Of these, 306 people have also received a stage 2 hepatitis C payment from the Skipton Fund in respect of their developing cirrhosis, liver cancer, B-Cell Non Hodgkin's Lymphoma or receiving a liver transplant as a result of their Hepatitis C infection contracted through their NHS treatment.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 21/10/2014 16:23:58 answering member 3918 label Biography information for Jane Ellison
tabling member	1533 label Biography information for Dame Diana Johnson